// Biotech and Pharma Therapeutics
J&J plans to split into two companies, separating consumer products and pharmaceutical businesses
Shares rose by about 3% in premarket trading after the announcement.
www.cnbc.com
EU pharmaceutical giants run old, vulnerable apps and fail to use encryption in login forms | ZDNet
New research highlights hundreds of companies that are at risk of cyberattacks.
www.zdnet.com
80% of EU Pharmaceutical Businesses Are ‘Critically Exposed’ to Cyberattacks: Report
According to research, more and more EU pharmaceutical giants have been struggling with cybersecurity prevention. Here’s the report about this.
www.techtimes.com
Pharma Price Controls aren’t the simple answer they promise to be
Why is it that an overwhelming majority of the world’s “cancer tourists” — people who travel abroad to obtain cancer care — find themselves on a plane to the United States?
stanfordreview.org
100 years of insulin: a technical success but an access failure
The isolation of insulin in 1921 and its subsequent delivery to a 14-year-old boy
in a diabetic coma in Toronto in 1922 was a ground-breaking scientific and clinical
achievement that has transformed diabetes care and is celebrated in this themed issue
of The Lancet. But despite the altruistic sentim…
in a diabetic coma in Toronto in 1922 was a ground-breaking scientific and clinical
achievement that has transformed diabetes care and is celebrated in this themed issue
of The Lancet. But despite the altruistic sentim…
www.thelancet.com
// 4th Industrial Revolution
AI hiring levels in the pharmaceutical industry dropped in September 2021
The proportion of pharmaceutical companies hiring for artificial intelligence related positions dropped in September 2021, with 30.4% of the companies...Read More...
www.pharmaceutical-technology.com
New AI Collaborations Reflect Rapid Growth in Pharmaceutical Industry | BioSpace
As the capabilities have been proven, AI is establishing a firm foothold in the key areas of R&D, drug development, clinical trials, and, to some extent, patient-facing products.
www.biospace.com
Revealed: the pharma companies leading the way in artificial intelligence
Novartis and Johnson & Johnson are among the companies best positioned to take advantage of future artificial intelligence disruption in...
www.pharmaceutical-technology.com
Google launches DeepMind 2, a pharmaceutical hullabaloo
Isomorphic Labs is Alphabet’s newest spinoff. The media’s in love with this darling little company run by the head of DeepMind. Should it be?
thenextweb.com
Johnson & Johnson CEO joins Apple’s board of directors – TechCrunch
Alex Gorsky, the chairman and CEO of Johnson & Johnson, has joined Apple’s board of directors. Gorsky’s move to Apple’s board comes ahead of his planned departure as CEO of Johnson & Johnson in January 2022. It also coincides with Apple focusing more on health technology. It’s not surprisin…
techcrunch.com
// Business & Markets
Traders Should Be Stopped Out of Biohaven Pharmaceutical
In his first "Executive Decision" segment of Wednesday's Mad Money program, Jim Cramer spoke with Vlad Coric, CEO of Biohaven Pharmaceutical (BHVN) , the biotech. Biohaven just announced a global partnership with Pfizer (PFE) to bring its migraine treatment, Nurtec ODT, to patients outside the U.S. Coric said in the deal, Biohaven retains the U.S. rights to Nurtec, but leverages Pfizer's global presence to commercialize the drug around the globe.
realmoney.thestreet.com
Organon to Acquire Forendo Pharma | BioSpace
Organon (NYSE: OGN), and Forendo Pharma today announced that the companies have entered into a definitive agreement, under which Organon will acquire Forendo, a clinical-stage drug development company focused on novel treatments in women’s health.
www.biospace.com
Investors are betting that Pfizer’s ‘game-changing’ antiviral pill will reduce demand for COVID vaccines
Pfizer’s new pill Paxlovid cuts the risk of severe COVID-19 outcomes, but doctors say it’s no substitute for a vaccine.
fortune.com
.jpg)
// Legal & Regulatory
Celgene Corp. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2021) | JD Supra
The question of the proper court for a branded pharmaceutical maker to bring suit against an Abbreviated New Drug Application filer under the...
www.jdsupra.com
FDA Issues Final and Draft Guidances on Biosimilar Development under BPCIA | JD Supra
In September, the U.S. Food and Drug Administration issued Final Guidance entitled “Questions and Answers on Biosimilar Development and the BPCI Act:...
www.jdsupra.com
Johnson & Johnson scores reversal of landmark $465M opioid ruling in Oklahoma
For years, Johnson & Johnson has been battling lawsuits alleging it played a role in creating the nationwide opioid epidemic. On Tuesday, just days after a high-profile trial win, the company scored major relief in appeals in a separate case.
www.fiercepharma.com
/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F618bb4fd4b6dcbb9db1a3887%2F0x0.jpg%3FcropX1%3D0%26cropX2%3D1729%26cropY1%3D45%26cropY2%3D1018)
Government Legal Battle Looms Over Who Should Take Credit For Moderna Vaccine
The director of the U.S. NIH said it will fight to have its scientists recognized on a key patent for Moderna’s vaccine, which the biotech insists it developed alone.
www.forbes.com
/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F618aff30f6ba9918536702dc%2F0x0.jpg)
Legal Challenges To OSHA’s Vaccination And Testing Emergency Temporary Standard
The main legal arguments against OSHA’s Vaccination and Testing Emergency Temporary Standard include violations of the Tenth Amendment, OSHA exceeding its statutory, OSHA not creating the ETS properly and the workplaces risks not justifying the imposition of the ETS.
www.forbes.com
// Research & Development
/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F618d4640fba7c74f3f6d9951%2F0x0.jpg)
Council Post: How Digital Transformation Could Change Research And Development For Pharmaceutical And Beauty Companies
Digital technologies have the potential to transform cosmetics and pharmaceutical companies into truly consumer-focused industries and support R&D’s partnership with marketing departments.
www.forbes.com
Burns Market Expected to Exhibit Dynamic Growth at an Increased CAGR of 1.96% in the 7MM for the Study Period 2018-30, Analyzes DelveInsight
/PRNewswire/ -- DelveInsight’s Burns Market Insights report proffers a detailed comprehension of Burns market size by treatment, epidemiology, emerging...
www.prnewswire.com
Detailed Roche study results muddy another Alzheimer’s hypothesis
Data presented at an Alzheimer’s meeting raised more questions about the seeming benefit of Roche and AC Immune’s drug semorinemab, which they claim is the first of its kind to slow deterioration of memory.
www.biopharmadive.com
// Politics
Pharmaceutical industry likely to shatter its lobbying record as it works to shape Democrats’ spending bill
In September, Rep. Andy Kim (D-N.J.) began noticing mailers arriving at homes across his district, including his own and that of his parents, with an alarming message. The mailers alleged that Kim was intent on preventing Medicare patients from getting the drugs they needed.
www.washingtonpost.com
Congressional Republicans Propose to Abolish America Invents Act (and a Bit More) | JD Supra
It being the holiday season in America, it is perhaps appropriate that patent traditionalists get something more than coal in their stocking from...
www.jdsupra.com
Office of the Governor | Governor Murphy Signs Legislation Promoting Transparency on the New Jersey Drug Utilization Review Board
Governor Phil Murphy today signed legislation (A-277/S-2035) that requires public members of the New Jersey Drug Utilization Review Board to submit disclosures of financial interests and involvement in pharmaceutical distributors, manufacturers, or benefits managers. The bill continues the Murphy Administration’s efforts to promote transparency and integrity in health care.
www.nj.gov
